<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02238938</url>
  </required_header>
  <id_info>
    <org_study_id>PERLA</org_study_id>
    <secondary_id>PV 4580</secondary_id>
    <nct_id>NCT02238938</nct_id>
  </id_info>
  <brief_title>Piecemeal Versus En Bloc Resection of Large Rectal Adenomas</brief_title>
  <acronym>PERLA</acronym>
  <official_title>Piecemeal Versus En Bloc Resection of Large Rectal Adenomas -A Prospective, Randomized Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, colonoscopy is the safest way to detect bowel tumors and polyps, since these can
      be biopsied and removed in one working process. If the size of adenomas is larger than 2 cm,
      resections are usually done in a hospital setting. For the resection of large adenomas,
      different approaches can be used. The so-called piecemeal resection is done with snares, to
      cut off parts of the adenoma piece by piece until the whole adenoma is resected. This
      technique is the standard therapy, but is not required for very large adenomas, which can
      often show cell alterations that indicate cancer. Therefore these adenomas should be resected
      in one piece. This is done by the so-called en-bloc resection. For this kind of therapy,
      different endoscopic knifes are use to cut off the adenoma as a whole. Both resection
      techniques are done usually by previous injection of saline or other liquids to elevate the
      lesion from its bottom tissue.

      Although the piecemeal resection of large adenoma is the standard therapy, it shows
      recurrence rates of 10 to 25%, which afford repeated therapies and follow up controls.
      En-bloc resections, though, are expected to have less recurrence rates but are much more
      complex to perform. They have higher complication rates especially in the West, where it has
      bee introduced only a couple of years ago.

      The data situation regarding safety and efficacy of both therapies is low. This study is the
      first one ever to compare piecemeal EMR and ESD in a randomized way. The study might have
      influence on the logistics of future adenoma processing and patient flow.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In 20 to 35% of colonoscopies due to symptoms or for prevention polyps, so-called adenoma,
      are found. Currently, colonoscopy is the best way to detect bowel tumors and polyps, since
      these can be biopsied and removed in one working process. If the size of adenoma is larger
      than 2 cm, resections are usually done in a hospital setting. Foremost for flat adenoma, the
      resection by snares piece by piece, the so-called piecemeal polypectomy, or piecemeal
      endoscopic mucosal resection (EMR), is state of the art. Resection will usually follow a
      submucosal saline injection (saline assisted polypectomy). Recurrences occur in 10 up to 25
      %, requiring a reapplication of endoscopic therapy and follow up examinations.

      Depending on the size of adenoma, increasing amounts of cell alterations of an advanced stage
      such as high grade dysplasia / intraepithelial neoplasia (HGIN) up to early cancer are found.
      In these cases, for histo-pathological and oncological reasons, a resection in a solitary
      manner (en-bloc resection) is necessary to evaluate the completeness of resection properly.
      Also, former studies showed that recurrence rate could be decreased considerably by en-bloc
      resections, since the aim is to perform a complete resection basally and laterally. New
      endoscopic techniques of en-bloc resections have been introduced since a couple of years,
      using several endoscopic knifes to cut adenoma down after submucosal injection of liquid and
      consecutively dissect it from the tissue underneath. This technique is mostly called
      endoscopic submucosal dissection (ESD), and, with not too large adenoma, can be combined with
      snare resection, too. The complexity of this method though is much larger than that of snare
      resection. Therefore, the western success rate is considerably less than in Japan, where it
      was developed first, and where higher numbers of cases exist in the upper GI tract as well as
      in the lower GI tract. All in all, the complication rate of en-bloc resection is higher than
      that of snare resection. Those complications, mostly perforations, are endoscopically
      controllable in most cases, though.

      In comparison with Japan, Korea or China, early malign lesions oft he upper GI tract in the
      West are rare. Therefore, this study will be conducted on (colo)rectal lesions, which appear
      much more often in the West.

      All in all, for efficacy (resection in total, number of recurrences) and risk (perforations),
      there is an indistinct data situation between piecemeal resection (EMR) and en-bloc resection
      (ESD). Up to now, no randomised comparing data exist. The planned study is the first
      randomised study between ESD and piecemeal EMR at all, since there are no studies been done
      for the upper GI tract, either. For reasons of complexity, ESD will conceivably remain a
      method for specialized centers, while piecemeal polypectomies are done in numerous hospitals.
      Therefore, the outcomes of this study will have influence on future logistics in
      polypectomies and flow of patients with large colorectal adenoma.

      Piecemeal resection will be done by snare following marking and submucosal injection of
      saline or equivalent liquids. Small leftover adenoma tissue will be resected thoroughly by
      snare or forceps. High resolution endoscopes are mandatory.

      After three months, an Argon plasma coagulation (APC) therapy will follow any piecemeal
      resection, if necessary, another resection of leftover adenoma will be done. This second
      session can be done by sigmoidoscopy.

      En- bloc resection is done after marking by use of different customary endoscopic knifes
      including combining devices as hybrid knife to cut down the lesion. After submucosal
      injection of liquid (saline or equivalent) to elevate the tissue it will be dissected and
      removed by a snare of adequate size solitarily. Since the aim of this method is the total
      resection basally and laterally, only one session is intended.

      Follow-up care: sigmoidoscopy after 6 and 18 months, colonoscopy after 36 months each after
      the end of the primary therapy session(s). Diagnostics will be done endoscopically and
      histologically of at least 6 biopsies if the size of lesion was up to 3 cm, and of at least
      10 biopsies for larger lesions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success rate of complete resection</measure>
    <time_frame>6 and 18 months after primary therapy</time_frame>
    <description>success rate is confirmed by endoscopical diagnostics as well as histological diagnostics (at lest 6 biopsies in lesions up to 3 cm size, at least 10 biopsies in larger lesions). Patients with no complete resection will be treated further according to clinical requirement, depending on histology.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>en-bloc group: rate of R0 resections</measure>
    <time_frame>timeline 0, day of en-bloc resection</time_frame>
    <description>This parameter is regarding histopathology. Since piecemeal resections do not allow such a diagnosis, this parameter is only for the en-bloc resected group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrence rate after complete adenoma resection</measure>
    <time_frame>36 months after initial resection</time_frame>
    <description>Since early recurrences can evolve from leftover tumor cells and will become manifest after a time, the third control after two controls with negative biopsies.has been chosen to be the gold standard.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>progress of therapy in patients with incomplete resection and recurrences</measure>
    <time_frame>36 months after initial resection</time_frame>
    <description>patients will be treated further according to treatment standard depending on endoscopical and histological findings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>differences in the subgroups of adenomas</measure>
    <time_frame>5 years</time_frame>
    <description>size, shape according to nice classification, low-grade and high grade intraepithelial adenomas, sm1 carcinomas</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>required time for the initial procedure</measure>
    <time_frame>timeline 0, day of initial resection</time_frame>
    <description>for piecemeal resections including second procedure with APC therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications including success of complication management</measure>
    <time_frame>5 years</time_frame>
    <description>rate of complications that need intervention, e.g.
perforation (intra - and post procedural, surgery, additional procedures such as antibiotics, monitoring, intensive care
secondary haemorrhage (second look endoscopy, surgery)
infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications through patient sedation</measure>
    <time_frame>timeline 0, day of initial resection</time_frame>
    <description>depending on sedation standards of the participating centers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>resolution of tumor board for post resections and outcomes of patients with carcinoma histology</measure>
    <time_frame>5 years</time_frame>
    <description>patients with carcinoma histology will be discussed by a of tumor board</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Colorectal Adenoma With Mild Dysplasia</condition>
  <condition>Colorectal Adenoma With Severe Dysplasia</condition>
  <condition>Colorectal Adenomatous Polyp</condition>
  <condition>Colorectal Low Grade Intraepithelial Neoplasia</condition>
  <condition>Colorectal High Grade Intraepithelial Neoplasia</condition>
  <arm_group>
    <arm_group_label>en-bloc resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>En- bloc resection is done after marking by use of different customary endoscopic knifes including combining devices as hybrid knife to cut down the lesion. After submucosal injection of liquid (saline or equivalent) to elevate the tissue it will be dissected and removed by a snare of adequate size solitarily. Since the aim of this method is the total resection basally and laterally, only one session is intended.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>piecemeal resection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Piecemeal resection will be done by snare following marking and submucosal injection of saline or equivalent liquids. Small leftover adenoma tissue will be resected thoroughly by snare or forceps. High resolution endoscopes are mandatory.
After three months, an APC therapy will follow any piecemeal resection, if necessary, another resection of leftover adenoma will be done. This second session can be done by sigmoidoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>en-bloc resection</intervention_name>
    <description>En- bloc resection after marking by use of different customary endoscopic knifes including combining devices as hybrid knife to cut down the lesion. After submucosal injection of liquid (saline or equivalent) to elevate the tissue it will be dissected and removed by a snare of adequate size solitarily.</description>
    <arm_group_label>en-bloc resection</arm_group_label>
    <other_name>endoscopic submucosal dissection</other_name>
    <other_name>ESD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>piecemeal resection</intervention_name>
    <description>Piecemeal resection is done by snare after marking and submucosal injection of saline or equivalent liquids. Small leftover adenoma tissue will be resected thoroughly by snare or forceps.
After three months, an APC therapy will follow any piecemeal resection, if necessary, another resection of leftover adenoma will be done.</description>
    <arm_group_label>piecemeal resection</arm_group_label>
    <other_name>piecemeal polypectomy</other_name>
    <other_name>piecemeal endoscopic mucosal resection</other_name>
    <other_name>piecemeal EMR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with large non pedunculated colorectal adenomas designated for endoscopic
             resection up to 15 cm ab ano, length 2 cm to 5 cm, maximum hemicircumferential

          -  age &gt; 18 years

          -  signed Informed Consent

        Exclusion Criteria:

          -  adenomas smaller or larger than described above

          -  more than one large rectal adenoma

          -  adenomas with known or suspected carcinoma, proven by previous biopsies

          -  adenomas with known or suspected carcinoma that do not seem to be resectable by
             endoscopy, e.g. ulcers, suspected infiltration of submucosa after endoscopic or
             ultrasound diagnostics

          -  patients with chronic inflammatory bowel diseases

          -  severe general disease, including metastasising carcinomas

          -  coagulation abnormalities or anticoagulant drug use which make resection therapy
             impossible

          -  bad general state of health (American Society of Anesthesiologists Classification
             (ASA) IV or more)

          -  pregnancy and lactation

          -  recurrence or leftover dysplasia after extended endoscopic or surgical therapy
             (transanal endoscopic microsurgery (TEM))
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Rösch, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Eppendorf, Hamburg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Rösch, Prof. Dr.</last_name>
    <phone>+49+40 7410</phone>
    <phone_ext>50098</phone_ext>
    <email>t.roesch@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guido Schachschal, Dr.</last_name>
    <phone>+4940 7410</phone>
    <phone_ext>50814</phone_ext>
    <email>g.schachschal@uke.uni-hamburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sana Klinikum Lichtenberg</name>
      <address>
        <city>Berlin</city>
        <zip>10365</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dirk Hartmann, PD Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Dirk Hartmann, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vivantes Wenckebach-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>12099</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mario Anders, Professor</last_name>
      <phone>+4930 130 19</phone>
      <phone_ext>2760</phone_ext>
      <email>mario.anders@vivantes.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Rösch, Prof. Dr</last_name>
      <phone>+49 40 7410</phone>
      <phone_ext>50098</phone_ext>
      <email>t.roesch@uke.de</email>
    </contact>
    <contact_backup>
      <last_name>Guido Schachschal, Dr.</last_name>
      <phone>+49 40 7410</phone>
      <phone_ext>50814</phone_ext>
    </contact_backup>
    <investigator>
      <last_name>Thomas Rösch, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guido Schachschal, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulrike W Denzer, PD Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefan Groth, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katharina Zimmermann-Fraedrich, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik Barmbek</name>
      <address>
        <city>Hamburg</city>
        <zip>22291</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Siegbert Faiss, PD Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Siegbert Faiss, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Bernward Krankenhaus</name>
      <address>
        <city>Hildesheim</city>
        <zip>31134</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludger Leifeld, Professor</last_name>
      <email>prof.dr.l.leifeld@bernward-khs.de</email>
    </contact>
    <investigator>
      <last_name>Ludger Leifeld, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Barmherzige Brüder Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Pech, PD Dr.</last_name>
      <phone>+49 941 369</phone>
      <phone_ext>2050</phone_ext>
      <email>Oliver.Pech@barmherzige-regensburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Dominic Brookman-Amissah</last_name>
      <phone>+49 941 369</phone>
      <phone_ext>94222</phone_ext>
      <email>dominic.brookman-amissah@barmherzige-regensburg.de</email>
    </contact_backup>
    <investigator>
      <last_name>Oliver Pech, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominic Brookman-Amissah, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Risio M. The natural history of colorectal adenomas and early cancer. Pathologe. 2012 Nov;33 Suppl 2:206-10. doi: 10.1007/s00292-012-1640-6. Review.</citation>
    <PMID>22945585</PMID>
  </reference>
  <reference>
    <citation>Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, Schnell TG, Chejfec G, Campbell DR, Kidao J, Bond JH, Nelson DB, Triadafilopoulos G, Ramirez FC, Collins JF, Johnston TK, McQuaid KR, Garewal H, Sampliner RE, Esquivel R, Robertson D. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007 Oct;133(4):1077-85.</citation>
    <PMID>17698067</PMID>
  </reference>
  <reference>
    <citation>Saini SD, Kim HM, Schoenfeld P. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc. 2006 Oct;64(4):614-26. Review.</citation>
    <PMID>16996358</PMID>
  </reference>
  <reference>
    <citation>Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, Kuipers EJ, Fockens P, Kraaijenhagen RA, Bossuyt PM. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer Epidemiol. 2013 Jun;37(3):278-83. doi: 10.1016/j.canep.2013.02.004. Epub 2013 Mar 9.</citation>
    <PMID>23491770</PMID>
  </reference>
  <reference>
    <citation>van Heijningen EM, Lansdorp-Vogelaar I, Kuipers EJ, Dekker E, Lesterhuis W, Ter Borg F, Vecht J, De Jonge V, Spoelstra P, Engels L, Bolwerk CJ, Timmer R, Kleibeuker JH, Koornstra JJ, van Ballegooijen M, Steyerberg EW. Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology. 2013 Jun;144(7):1410-8. doi: 10.1053/j.gastro.2013.03.002. Epub 2013 Mar 7.</citation>
    <PMID>23499951</PMID>
  </reference>
  <reference>
    <citation>Jang JH, Balik E, Kirchoff D, Tromp W, Kumar A, Grieco M, Feingold DL, Cekic V, Njoh L, Whelan RL. Oncologic colorectal resection, not advanced endoscopic polypectomy, is the best treatment for large dysplastic adenomas. J Gastrointest Surg. 2012 Jan;16(1):165-71; discussion 171-2. doi: 10.1007/s11605-011-1746-9. Epub 2011 Nov 5.</citation>
    <PMID>22058042</PMID>
  </reference>
  <reference>
    <citation>Repici A, Hassan C, De Paula Pessoa D, Pagano N, Arezzo A, Zullo A, Lorenzetti R, Marmo R. Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review. Endoscopy. 2012 Feb;44(2):137-50. doi: 10.1055/s-0031-1291448. Epub 2012 Jan 23. Review.</citation>
    <PMID>22271024</PMID>
  </reference>
  <reference>
    <citation>Farhat S, Chaussade S, Ponchon T, Coumaros D, Charachon A, Barrioz T, Koch S, Houcke P, Cellier C, Heresbach D, Lepilliez V, Napoleon B, Bauret P, Coron E, Le Rhun M, Bichard P, Vaillant E, Calazel A, Bensoussan E, Bellon S, Mangialavori L, Robin F, Prat F; SFED ESD study group. Endoscopic submucosal dissection in a European setting. A multi-institutional report of a technique in development. Endoscopy. 2011 Aug;43(8):664-70. doi: 10.1055/s-0030-1256413. Epub 2011 May 27.</citation>
    <PMID>21623560</PMID>
  </reference>
  <reference>
    <citation>Probst A, Pommer B, Golger D, Anthuber M, Arnholdt H, Messmann H. Endoscopic submucosal dissection in gastric neoplasia - experience from a European center. Endoscopy. 2010 Dec;42(12):1037-44. doi: 10.1055/s-0030-1255668. Epub 2010 Oct 22.</citation>
    <PMID>20972955</PMID>
  </reference>
  <reference>
    <citation>Ribeiro-Mourão F, Pimentel-Nunes P, Dinis-Ribeiro M. Endoscopic submucosal dissection for gastric lesions: results of an European inquiry. Endoscopy. 2010 Oct;42(10):814-9. doi: 10.1055/s-0030-1255778. Epub 2010 Sep 30.</citation>
    <PMID>20886399</PMID>
  </reference>
  <reference>
    <citation>Neuhaus H, Terheggen G, Rutz EM, Vieth M, Schumacher B. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus. Endoscopy. 2012 Dec;44(12):1105-13. doi: 10.1055/s-0032-1310155. Epub 2012 Sep 11.</citation>
    <PMID>22968641</PMID>
  </reference>
  <reference>
    <citation>Probst A, Golger D, Anthuber M, Märkl B, Messmann H. Endoscopic submucosal dissection in large sessile lesions of the rectosigmoid: learning curve in a European center. Endoscopy. 2012 Jul;44(7):660-7. doi: 10.1055/s-0032-1309403. Epub 2012 Apr 23.</citation>
    <PMID>22528673</PMID>
  </reference>
  <reference>
    <citation>Adler A, Roll S, Marowski B, Drossel R, Rehs HU, Willich SN, Riese J, Wiedenmann B, Rösch T; Berlin Private-Practice Gastroenterology Working Group. Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1). Dis Colon Rectum. 2007 Oct;50(10):1628-38.</citation>
    <PMID>17694415</PMID>
  </reference>
  <reference>
    <citation>Redaelli A, Cranor CW, Okano GJ, Reese PR. Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer. Pharmacoeconomics. 2003;21(17):1213-38. Review.</citation>
    <PMID>14986736</PMID>
  </reference>
  <reference>
    <citation>Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(9856):1840-50. doi: 10.1016/S0140-6736(12)60919-2. Epub 2012 Oct 16.</citation>
    <PMID>23079588</PMID>
  </reference>
  <reference>
    <citation>van den Broek FJ, de Graaf EJ, Dijkgraaf MG, Reitsma JB, Haringsma J, Timmer R, Weusten BL, Gerhards MF, Consten EC, Schwartz MP, Boom MJ, Derksen EJ, Bijnen AB, Davids PH, Hoff C, van Dullemen HM, Heine GD, van der Linde K, Jansen JM, Mallant-Hent RC, Breumelhof R, Geldof H, Hardwick JC, Doornebosch PG, Depla AC, Ernst MF, van Munster IP, de Hingh IH, Schoon EJ, Bemelman WA, Fockens P, Dekker E. Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study). BMC Surg. 2009 Mar 13;9:4. doi: 10.1186/1471-2482-9-4.</citation>
    <PMID>19284647</PMID>
  </reference>
  <reference>
    <citation>Moss A, Bourke MJ, Williams SJ, Hourigan LF, Brown G, Tam W, Singh R, Zanati S, Chen RY, Byth K. Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia. Gastroenterology. 2011 Jun;140(7):1909-18. doi: 10.1053/j.gastro.2011.02.062. Epub 2011 Mar 8.</citation>
    <PMID>21392504</PMID>
  </reference>
  <reference>
    <citation>Kim HH, Kim JH, Park SJ, Park MI, Moon W. Risk factors for incomplete resection and complications in endoscopic mucosal resection for lateral spreading tumors. Dig Endosc. 2012 Jul;24(4):259-66. doi: 10.1111/j.1443-1661.2011.01232.x. Epub 2012 Feb 7.</citation>
    <PMID>22725112</PMID>
  </reference>
  <reference>
    <citation>Kobayashi N, Yoshitake N, Hirahara Y, Konishi J, Saito Y, Matsuda T, Ishikawa T, Sekiguchi R, Fujimori T. Matched case-control study comparing endoscopic submucosal dissection and endoscopic mucosal resection for colorectal tumors. J Gastroenterol Hepatol. 2012 Apr;27(4):728-33. doi: 10.1111/j.1440-1746.2011.06942.x.</citation>
    <PMID>22004124</PMID>
  </reference>
  <reference>
    <citation>Ahlawat SK, Gupta N, Benjamin SB, Al-Kawas FH. Large colorectal polyps: endoscopic management and rate of malignancy: does size matter? J Clin Gastroenterol. 2011 Apr;45(4):347-54. doi: 10.1097/MCG.0b013e3181f3a2e0.</citation>
    <PMID>20871408</PMID>
  </reference>
  <reference>
    <citation>Ah Soune P, Ménard C, Salah E, Desjeux A, Grimaud JC, Barthet M. Large endoscopic mucosal resection for colorectal tumors exceeding 4 cm. World J Gastroenterol. 2010 Feb 7;16(5):588-95.</citation>
    <PMID>20128027</PMID>
  </reference>
  <reference>
    <citation>Hurlstone DP, Sanders DS, Cross SS, George R, Shorthouse AJ, Brown S. A prospective analysis of extended endoscopic mucosal resection for large rectal villous adenomas: an alternative technique to transanal endoscopic microsurgery. Colorectal Dis. 2005 Jul;7(4):339-44.</citation>
    <PMID>15932555</PMID>
  </reference>
  <reference>
    <citation>Pigot F, Bouchard D, Mortaji M, Castinel A, Juguet F, Chaume JC, Faivre J. Local excision of large rectal villous adenomas: long-term results. Dis Colon Rectum. 2003 Oct;46(10):1345-50.</citation>
    <PMID>14530673</PMID>
  </reference>
  <reference>
    <citation>Doniec JM, Löhnert MS, Schniewind B, Bokelmann F, Kremer B, Grimm H. Endoscopic removal of large colorectal polyps: prevention of unnecessary surgery? Dis Colon Rectum. 2003 Mar;46(3):340-8.</citation>
    <PMID>12626909</PMID>
  </reference>
  <reference>
    <citation>Pohl H, Srivastava A, Bensen SP, Anderson P, Rothstein RI, Gordon SR, Levy LC, Toor A, Mackenzie TA, Rosch T, Robertson DJ. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013 Jan;144(1):74-80.e1. doi: 10.1053/j.gastro.2012.09.043. Epub 2012 Sep 25.</citation>
    <PMID>23022496</PMID>
  </reference>
  <reference>
    <citation>Rösch T, Sarbia M, Schumacher B, Deinert K, Frimberger E, Toermer T, Stolte M, Neuhaus H. Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy. 2004 Sep;36(9):788-801.</citation>
    <PMID>15326574</PMID>
  </reference>
  <reference>
    <citation>Neuhaus H, Costamagna G, Devière J, Fockens P, Ponchon T, Rösch T; ARCADE Group. Endoscopic submucosal dissection (ESD) of early neoplastic gastric lesions using a new double-channel endoscope (the &quot;R-scope&quot;). Endoscopy. 2006 Oct;38(10):1016-23.</citation>
    <PMID>17058167</PMID>
  </reference>
  <reference>
    <citation>Adler A, Wegscheider K, Lieberman D, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Mroß M, Scheel M, Schröder A, Gerber K, Stange G, Roll S, Gauger U, Wiedenmann B, Altenhofen L, Rosch T. Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut. 2013 Feb;62(2):236-41. doi: 10.1136/gutjnl-2011-300167. Epub 2012 Mar 22.</citation>
    <PMID>22442161</PMID>
  </reference>
  <reference>
    <citation>Adler A, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Scheel M, Schröder A, Yenerim T, Wiedenmann B, Gauger U, Roll S, Rösch T. Latest generation, wide-angle, high-definition colonoscopes increase adenoma detection rate. Clin Gastroenterol Hepatol. 2012 Feb;10(2):155-9. doi: 10.1016/j.cgh.2011.10.026. Epub 2011 Nov 2.</citation>
    <PMID>22056301</PMID>
  </reference>
  <reference>
    <citation>Adler A, Aschenbeck J, Yenerim T, Mayr M, Aminalai A, Drossel R, Schröder A, Scheel M, Wiedenmann B, Rösch T. Narrow-band versus white-light high definition television endoscopic imaging for screening colonoscopy: a prospective randomized trial. Gastroenterology. 2009 Feb;136(2):410-6.e1; quiz 715. doi: 10.1053/j.gastro.2008.10.022. Epub 2008 Oct 15.</citation>
    <PMID>19014944</PMID>
  </reference>
  <reference>
    <citation>Adler A, Pohl H, Papanikolaou IS, Abou-Rebyeh H, Schachschal G, Veltzke-Schlieker W, Khalifa AC, Setka E, Koch M, Wiedenmann B, Rösch T. A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect? Gut. 2008 Jan;57(1):59-64. Epub 2007 Aug 6.</citation>
    <PMID>17681999</PMID>
  </reference>
  <reference>
    <citation>Pohl H, Aschenbeck J, Drossel R, Schröder A, Mayr M, Koch M, Rothe K, Anders M, Voderholzer W, Hoffmann J, Schulz HJ, Liehr RM, Gottschalk U, Wiedenmann B, Rösch T. Endoscopy in Barrett's oesophagus: adherence to standards and neoplasia detection in the community practice versus hospital setting. J Intern Med. 2008 Oct;264(4):370-8. doi: 10.1111/j.1365-2796.2008.01977.x. Epub 2008 May 15.</citation>
    <PMID>18482289</PMID>
  </reference>
  <reference>
    <citation>Meining A, Ott R, Becker I, Hahn S, Mühlen J, Werner M, Höfler H, Classen M, Heldwein W, Rösch T. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance? Gut. 2004 Oct;53(10):1402-7.</citation>
    <PMID>15361485</PMID>
  </reference>
  <reference>
    <citation>Heldwein W, Dollhopf M, Rösch T, Meining A, Schmidtsdorff G, Hasford J, Hermanek P, Burlefinger R, Birkner B, Schmitt W; Munich Gastroenterology Group. The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy. 2005 Nov;37(11):1116-22.</citation>
    <PMID>16281142</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2014</study_first_submitted>
  <study_first_submitted_qc>September 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2014</study_first_posted>
  <last_update_submitted>May 5, 2017</last_update_submitted>
  <last_update_submitted_qc>May 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>piecemeal polypectomy</keyword>
  <keyword>piecemeal endoscopic mucosal resection (EMR)</keyword>
  <keyword>endoscopic submucosal dissection (ESD)</keyword>
  <keyword>endoscopic en-bloc resection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Adenomatous Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

